Christopher J. Burns
Clayton, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunity.
Journal: Nature immunology
Published: December 12, 2023
A constricted opening in Kir channels does not impede potassium conduction.
Journal: Nature communications
Published: October 09, 2019
TBK1 and IKKε Act Redundantly to Mediate STING-Induced NF-κB Responses in Myeloid Cells.
Journal: Cell reports
Published: March 11, 2019
HBO1 is required for the maintenance of leukaemia stem cells.
Journal: Nature
Published: September 05, 2018
Therapeutic Effects of a TANK-Binding Kinase 1 Inhibitor in Germinal Center-Driven Collagen-Induced Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 24, 2018
Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer.
Journal: Oncotarget
Published: October 27, 2017
Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors.
Journal: ACS medicinal chemistry letters
Published: September 25, 2017
Defining a therapeutic window for kinase inhibitors in leukemia to avoid neutropenia.
Journal: Oncotarget
Published: May 02, 2017
Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma.
Journal: Molecular cancer therapeutics
Published: February 22, 2017
Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD Mice.
Journal: Diabetes
Published: October 15, 2016
Last Updated: 09/26/2026